grunenthal.comWelcome | Grunenthal

Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts. You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options: Go to settings Accept ; Contact Creditor Relations Press Room Search Log In -- About us Responsibility Research & Development Partnering Jobs and career Media Our unique commitment to pain We are Grünenthal History Leadership Supervisory Board Global presence & sites Products Initiatives & Grants Our positions Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. ... About us ... Our unique commitment to pain A world free of pain. This is our shared vision. To bring it to life, we execute our strategy and work on our company’s culture – everyday, everywhere, every one of us. ... We are Grünenthal Although firmly rooted in Germany, today we are very much a growing global Business. ... History A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity. ... Leadership The Supervisory Board advises and controls the Corporate Executive Board and is elected by the shareholders’ summit. ... Supervisory Board Affiliates in Europe Affiliates in USA & Latin America Manufacturing Sites In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond. ... Global presence & sites Grünenthal’s product portfolio, brands, ingredients and indication range. ... Products We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital. ... Initiatives & Grants ... Our positions Society and the Environment Educated Access to Pain Management Compliance, Ethics and Transparency Thalidomide At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact for society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards. ... Responsibility ... Society and the Environment ... Educated Access to Pain Management At Grünenthal, we share the responsibility to act with integrity and conduct all of our research and business activities in compliance with applicable laws and regulations. ... Compliance, Ethics and Transparency ... Thalidomide R&D approach Collaboration Pipeline Strategic therapeutic areas Clinical trials Our company has a clear vision of a world free of pain and we maintain a laser-sharp focus on this vision in everything we do – especially in our research and development activities. ... Research & Development Innovation Hubs We follow a holistic and solution-agnostic approach to deliver highly effective pain treatments, building our programmes on a firm foundation of human pathophysiology and solid human target validation. ... R&D approach ... Collaboration ... Pipeline Peripheral neuropathic pain Chronic post-surgical pain Chronic low back pain Osteoarthritis Grünenthal’s therapeutic area strategy is pursuing four key indications: peripheral neuropathic pain, chronic postoperative pain, chronic low back pain, and osteoarthritis. ... Strategic therapeutic areas Clinical trial portal Clinical data sharing As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available. ... Clinical trials Areas of interest Public Private Partnerships We believe that success comes from close collaborations founded on a shared vision to develop innovative medicines for patients that suffer from diseases with high unmet needs. ... Partnering We strengthen and develop our core markets Europe, North America, Latin America and Asia through acquisitions, asset deals, in-licensing, commercialization and distribution deals. ... Areas of interest ... Public Private Partnerships Our Stories Press releases Statements Corporate publications Image resources Video resources Explore our media section and access a range of materials relating to our company, people, medicines and medical devices. ... Media Grünenthal is a global leader in pain management and related diseases. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. Explore our recent stories to see what drives us. ... Our Stories 2021 2020 2019 2018 2017 2016 2015 2014 2013 In this section you will find both current and archived press releases published from 2013 onwards by Grünenthal GmbH, Germany. ... Press releases ... Statements Journalists are invited to use our corporate publications for their reporting. The list contains business related publication like the company presentation or the code of conduct. . ... Corporate publications Journalists are invited to use images from our library to illustrate their reporting. The library contains company and R&D related pictures. ... Image resources The library contains a set of company footage. Journalists are invited to use the video material to illustrate their reporting. ... Video resources Search Results Search For a world free of pain Grünenthal is a global leader in pain management and related diseases. As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain. ... Find out more in Grünenthal’s 2019/20 annual report Grünenthal Stories View All Every moment matters Patients , Grünenthal Foundation 29 April 2021 Grünenthal acquires Mestex AG Pain , Strategy , Partnering 12 April 2021 Grünenthal’s first Environmental, Social and Governance Rating puts us ahead of our peers Environment , Society , Awards 07 April 2021 New phase III study with QUTENZA® Access to healthcare , Pain , Patients 30 March 2021 Grünenthal – a Great Place to Work® Culture , HR , People 10 March 2021 Understanding cancer-related pain Science , Society , Culture 18 February 2021 International Day of Women and Girls in Science Science , Society , Culture 11 February 2021 Leaders in pain management in Spain Patients , Pain , Pain and quality of life 04 February 2021 Excellent logistics in Colombia Logistics , Contract Manufacturing , Patients 21 January 2021 Dignity at the end of life Access to healthcare , Pain , Society 14 January 2021 Phase I Study started Patients , Pain , Clinical Study 16 December 2020 Empowering patient engagement in R&D Collaboration , Patients , Public Private Partnership 25 November 2020 How Artificial Intelligence plays a key role in pharmaceutical R&D Research 13 October 2020 The courage to fail Culture , People , Strategy 15 September 2020 Keeping patients safe Contract Manufacturing , Patients , Supply Chain 01 October 2020 Relentless focus on patients Patients , Access to healthca...